These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 34207557)
1. Nucleotide Excision Repair: From Molecular Defects to Neurological Abnormalities. Krasikova Y; Rechkunova N; Lavrik O Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207557 [TBL] [Abstract][Full Text] [Related]
2. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Brooks PJ Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928 [TBL] [Abstract][Full Text] [Related]
3. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. Brooks PJ DNA Repair (Amst); 2008 Jul; 7(7):1168-79. PubMed ID: 18495558 [TBL] [Abstract][Full Text] [Related]
4. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. Cleaver JE J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759 [TBL] [Abstract][Full Text] [Related]
5. The cyclopurine deoxynucleosides: DNA repair, biological effects, mechanistic insights, and unanswered questions. Brooks PJ Free Radic Biol Med; 2017 Jun; 107():90-100. PubMed ID: 28011151 [TBL] [Abstract][Full Text] [Related]
6. The oxidative DNA lesion 8,5'-(S)-cyclo-2'-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. Brooks PJ; Wise DS; Berry DA; Kosmoski JV; Smerdon MJ; Somers RL; Mackie H; Spoonde AY; Ackerman EJ; Coleman K; Tarone RE; Robbins JH J Biol Chem; 2000 Jul; 275(29):22355-62. PubMed ID: 10801836 [TBL] [Abstract][Full Text] [Related]
7. Ribosomal protein S3 associates with the TFIIH complex and positively regulates nucleotide excision repair. Park YJ; Kim SH; Kim TS; Lee SM; Cho BS; Seo CI; Kim HD; Kim J Cell Mol Life Sci; 2021 Apr; 78(7):3591-3606. PubMed ID: 33464383 [TBL] [Abstract][Full Text] [Related]
8. Nucleotide excision repair activity on DNA damage induced by photoactivated methylene blue. Berra CM; de Oliveira CS; Garcia CC; Rocha CR; Lerner LK; Lima LC; Baptista Mda S; Menck CF Free Radic Biol Med; 2013 Aug; 61():343-56. PubMed ID: 23567189 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients. Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897 [TBL] [Abstract][Full Text] [Related]
10. Evidence for persistent UV-induced DNA damage and altered DNA damage response in xeroderma pigmentosa patient corneas. Akepogu J; Jakati S; Chaurasia S; Ramachandran C Exp Eye Res; 2024 Jun; 243():109901. PubMed ID: 38641197 [TBL] [Abstract][Full Text] [Related]
12. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer. Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616 [TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms. Abeti R; Zeitlberger A; Peelo C; Fassihi H; Sarkany RPE; Lehmann AR; Giunti P Br J Pharmacol; 2019 Nov; 176(22):4293-4301. PubMed ID: 30499105 [TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum--bridging a gap between clinic and laboratory. Moriwaki S; Kraemer KH Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401 [TBL] [Abstract][Full Text] [Related]
15. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma. Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756 [TBL] [Abstract][Full Text] [Related]
16. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy. Magnaldo T; Sarasin A Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993 [TBL] [Abstract][Full Text] [Related]
18. Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation. Musich PR; Li Z; Zou Y Adv Exp Med Biol; 2017; 996():41-54. PubMed ID: 29124689 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of xeroderma pigmentosum (XP) proteins. Koch SC; Simon N; Ebert C; Carell T Q Rev Biophys; 2016 Jan; 49():e5. PubMed ID: 27660069 [TBL] [Abstract][Full Text] [Related]
20. Signaling Pathways, Chemical and Biological Modulators of Nucleotide Excision Repair: The Faithful Shield against UV Genotoxicity. Kobaisi F; Fayyad N; Rezvani HR; Fayyad-Kazan M; Sulpice E; Badran B; Fayyad-Kazan H; Gidrol X; Rachidi W Oxid Med Cell Longev; 2019; 2019():4654206. PubMed ID: 31485292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]